[e-drug] Emerging markets fuel $ 665-685bn global market (3)

["Murat Civaner" <mcivaner@gmail.com>]

E-DRUG: Emerging markets fuel $ 665-685bn global market (3)
-----------------------------------------------------------

dear e-druggers,

I think IMS means Eastern Europe as the third region of
"emerging markets":

http://getir.net/t72

and here are the rising stars:

"The attractiveness of entering or expanding in such double-digit growth
markets as China, India, Russia and Turkey is clear.  No global
pharmaceutical company can ignore such a rich source of potential future or
it will find itself competing in an ever-shrinking part of the market. Some
are already shaping long-term strategic plans even as national healthcare
systems emerge."

This is concordant with a World Bank project which entirely change the
public health care system to a private one. MoH announced that they will set
up a National Drug Committee which will determine the drug policies, and
Committee will be a platform that seek the aggreement of all parties of the
sector. 

regards

Dr. Murat Civaner
Uludag University School of Medicine
Dept. of Medical Ethics
Bursa, Turkey
+90.224.295 4272
mcivaner@gmail.com